EKF Diagnostics Holdings plc is engaged in developing, manufacturing and supplying of products and services into the in-vitro diagnostic (IVD) market place. The Company manufactures and sells diagnostic instruments, reagents and certain ancillary products. The Company's point-of-care range includes hemoglobin analyzers, HbA1c analyzers and glucose analyzers for use in the screening, monitoring and diagnosis of patients, as well as rapid tests for pregnancy and common infectious diseases. The Company's Central Laboratory division includes a range of products for use in both large and small laboratory facilities. Its subsidiary, EKF Life Sciences, provides bulk diagnostic enzyme manufacturing and fermentation services. EKF Life Sciences specializes in producing enzymes, including Salicylate Hydroxylase and Beta-Hydroxybutyrate Dehydrogenase. Its products include Quo-Test A1c, Biosen C-Line and Biosen S-Line, STAT-Site M B-HB analyzer, sTNFR1 biomarker test kits and Altair 240.
Industry, Sector and Symbol:
- Sector: Healthcare
- Industry: Medical Monitoring Systems
- Sub-Industry: N/A
- Symbol: LON:EKF
- CUSIP: N/A
- Web: www.ekfdiagnostics.com/
Capitalization:- Market Cap: £105.13 million
- Outstanding Shares: 445,000,000
Average Prices:- 50 Day Moving Avg: GBX 24.58
- 200 Day Moving Avg: GBX 22.33
- 52 Week Range: GBX 14 - GBX 26.50
P/E:- Trailing P/E Ratio: 78.750
- P/E Growth: 0.000
Sales & Book Value:- Annual Revenue: £42.58 million
- Price / Sales: 2.47
- Book Value: GBX 0.13 per share
- Price / Book: 1.80
Profitability:- EBIDTA: £6.37 million
- Net Margins: 7.55%
- Return on Equity: 5.09%
- Return on Assets: 3.93%
Misc:- Average Volume: 989,990 shs.
Frequently Asked Questions for Ekf Diagnostics Holding PLC (LON:EKF)
What is Ekf Diagnostics Holding PLC's stock symbol?
Ekf Diagnostics Holding PLC trades on the London Stock Exchange (LON) under the ticker symbol "EKF."
Where is Ekf Diagnostics Holding PLC's stock going? Where will Ekf Diagnostics Holding PLC's stock price be in 2017?
1 equities research analysts have issued 1 year target prices for Ekf Diagnostics Holding PLC's stock. Their forecasts range from GBX 21 to GBX 21. On average, they expect Ekf Diagnostics Holding PLC's stock price to reach GBX 21 in the next year. View Analyst Ratings for Ekf Diagnostics Holding PLC.
Who are some of Ekf Diagnostics Holding PLC's key competitors?
Some companies that are related to Ekf Diagnostics Holding PLC include Organovo Holdings (ONVO), OncoCyte Corp (OCX), Zymeworks (ZYME), Allergy Therapeutics plc (AGY), Transenterix (TRXC), Transenterix (TRXC), Ocular Therapeutix (OCUL), Chromadex Corp (CDXC), Kadmon Holdings (KDMN), Asterias Biotherapeutics (AST), Asterias Biotherapeutics (AST), Synthetic Biologics (SYN), Sinclair Pharma PLC (SPH), Silence Therapeutics plc (SLN), Synthetic Biologics (SYN), Verona Pharma Plc (VRP), Summit Therapeutics PLC (SUMM) and Arch Therapeutics (ARTH).
Who are Ekf Diagnostics Holding PLC's key executives?
Ekf Diagnostics Holding PLC's management team includes the folowing people:
- Julian Huw Baines, Chief Executive Officer, Executive Director
- Richard Anthony Evans, Finance Director, Chief Operating Officer, Executive Director
- Christopher Harwood Bernard Mills, Non-Executive Chairman of the Board
- David Eric Evans, Non-Executive Deputy Chairman of the Board
- Carl Dominic Contadini, Non-Executive Director
- Adam Reynolds, Independent Non-Executive Director
How do I buy Ekf Diagnostics Holding PLC stock?
Shares of Ekf Diagnostics Holding PLC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is Ekf Diagnostics Holding PLC's stock price today?
One share of Ekf Diagnostics Holding PLC stock can currently be purchased for approximately GBX 23.63.
MarketBeat Community Rating for Ekf Diagnostics Holding PLC (LON EKF)MarketBeat's community ratings are surveys of what our community members think about Ekf Diagnostics Holding PLC and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Consensus Ratings for Ekf Diagnostics Holding PLC (LON:EKF) (How are Consensus Ratings Calculated?) MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Ratings Breakdown: | 1 Hold Rating |
| Consensus Rating: | Hold (Score: 2.00) |
| Consensus Price Target: | GBX 21 |
Analysts' Ratings History for Ekf Diagnostics Holding PLC (LON:EKF)
Show:
| Date | Firm | Action | Rating | Price Target | Details |
|---|
| 9/6/2017 | Panmure Gordon | Reiterated Rating | Hold | |  |
| 7/6/2017 | N+1 Singer | Reiterated Rating | corporate | | |
| 11/29/2016 | FinnCap | Reiterated Rating | Under Review | | |
(Data available from 9/22/2015 forward)
Earnings History for Ekf Diagnostics Holding PLC (LON:EKF)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for Ekf Diagnostics Holding PLC (LON:EKF)Current Year EPS Consensus Estimate: $0.750 EPS
Dividend History for Ekf Diagnostics Holding PLC (LON:EKF)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Ekf Diagnostics Holding PLC (LON:EKF)Insider Trades by Quarter for Ekf Diagnostics Holding PLC (LON:EKF)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 3/20/2017 | Christopher H B Mills | Insider | Buy | 8,000,000 | GBX 19 | £1,520,000 | |
| 7/15/2016 | Mills,Christopher H B | Insider | Buy | 9,000,000 | GBX 15 | £1,350,000 | |
| 6/24/2016 | Mills,Christopher H B | Insider | Buy | 2,613,957 | GBX 12 | £313,674.84 | |
| 6/23/2016 | Mills,Christopher H B | Insider | Buy | 2,000,000 | GBX 12 | £240,000 | |
| 6/21/2016 | Mills,Christopher H B | Insider | Buy | 4,500,000 | GBX 12 | £540,000 | |
| 6/17/2016 | Mills,Christopher H B | Insider | Buy | 532,781 | GBX 12 | £63,933.72 | |
| 6/9/2016 | Mills,Christopher H B | Insider | Buy | 447,666 | GBX 12 | £53,719.92 | |
(Data available from 1/1/2013 forward)
Headline Trends for Ekf Diagnostics Holding PLC (LON:EKF)
Latest Headlines for Ekf Diagnostics Holding PLC (LON:EKF)
| Source: |
|
| Date | Headline |
|---|
 | EKF Diagnostics Holdings Plc breached its 50 day moving average in a Bearish Manner : EKF-GB : September 19, 2017
finance.yahoo.com - September 19 at 6:13 PM |
 | EKF Diagnostics Trading In Line As It Swings To Interim Profit
www.morningstar.co.uk - September 13 at 12:01 AM |
 | EKF Diagnostics Trading In Line As It Swings To Interim Profit - London South East (registration) (blog)
www.lse.co.uk - September 11 at 11:48 PM |
 | Ekf Diagnostics Holding PLC (EKF) Receives Hold Rating from Panmure Gordon
www.americanbankingnews.com - September 6 at 7:20 AM |
| Ekf Diagnostics Holding PLC (EKF) Scheduled to Post Quarterly Earnings on Monday
www.americanbankingnews.com - September 4 at 2:23 AM |
| 3 Hot Shares That Might Take Off In September
finance.yahoo.com - September 1 at 6:33 PM |
| Ekf Diagnostics Holding PLC's (EKF) corporate Rating Reiterated at N+1 Singer
www.americanbankingnews.com - July 9 at 7:30 AM |
| EKF Diagnostics Expects Full-Year Results Ahead Of Market Forecasts
www.morningstar.co.uk - July 7 at 5:31 AM |
 | EKF Diagnostics Sees FY Adj EBITDA Ahead Of Market View; Stock Up
www.rttnews.com - July 7 at 5:31 AM |
| Cancellation of share options - London South East (registration) (blog)
www.lse.co.uk - June 28 at 3:14 AM |
| EKF Diagnostics Holdings Plc breached its 50 day moving average in a Bullish Manner : EKF-GB : June 19, 2017
finance.yahoo.com - June 19 at 1:34 PM |
| EKF Diagnostics Holdings Plc – Value Analysis (LONDON:EKF) : June 9, 2017
finance.yahoo.com - June 9 at 5:25 PM |
| EKF Diagnostics Holdings Plc breached its 50 day moving average in a Bearish Manner : EKF-GB : June 8, 2017
finance.yahoo.com - June 8 at 5:56 PM |
 | Hygea VCT plc : Update for the quarter ended 31 March 2017 - GlobeNewswire (press release)
globenewswire.com - May 19 at 8:05 AM |
| EKF Diagnostics Optimistic, Still Considering Potential Demerger - London South East (registration) (blog)
www.lse.co.uk - May 11 at 5:35 PM |
| EKF Diagnostics Holdings Plc :EKF-GB: Earnings Analysis: For the six months ended December 31, 2016 : May 5, 2017
finance.yahoo.com - May 5 at 10:09 PM |
| Ekf Diagnostics Holding PLC's (EKF) "Buy" Rating Reaffirmed at Panmure Gordon
www.americanbankingnews.com - April 20 at 7:36 PM |
| Panmure Gordon Raises Ekf Diagnostics Holding PLC (EKF) Price Target to GBX 21
www.americanbankingnews.com - April 15 at 9:15 PM |
| Hygea VCT plc : Annual Report and Accounts and Notice of AGM
globenewswire.com - April 10 at 4:43 PM |
 | The Top 50 Manufacturers of Hematology In-Vitro Diagnostics Analyzers, Reagents & Accessories Worldwide
www.prnewswire.com - March 29 at 11:37 AM |
| N+1 Singer Reaffirms "Corporate" Rating for Ekf Diagnostics Holding PLC (EKF)
www.americanbankingnews.com - March 25 at 8:55 PM |
| Insider Buying: Ekf Diagnostics Holding PLC (EKF) Insider Acquires 8,000,000 Shares of Stock
www.americanbankingnews.com - March 22 at 9:02 AM |
| Full Year 2016 EKF Diagnostics Holdings PLC Earnings Release - Before Market Open
biz.yahoo.com - March 20 at 7:39 PM |
 | This ‘special situation’ stock looks set to fly
uk.finance.yahoo.com - March 20 at 7:39 PM |
| Ekf Diagnostics Holding PLC’s (EKF) Buy Rating Reaffirmed at Panmure Gordon
www.americanbankingnews.com - March 15 at 11:09 PM |
| Global Diabetes Diagnostics Industry - PR Newswire (press release)
www.prnewswire.com - February 28 at 5:07 PM |
| Global Diabetes Diagnostics Industry
finance.yahoo.com - February 28 at 8:18 AM |
| EKF Diagnostics 2016 Revenue Outpaces Previous Guidance
www.morningstar.co.uk - January 9 at 5:45 PM |
| Does EKF Diagnostics Holding plc have more upside than GlaxoSmithKline plc after beating expectations?
uk.finance.yahoo.com - January 9 at 5:45 PM |
| EKF Diagnostics FY16 Overall Performance To Exceed Revised Market Forecasts
www.rttnews.com - January 9 at 2:46 AM |
| Oryx International Growth Fund Net Assets Beat Benchmark In - London South East (registration) (blog)
www.lse.co.uk - December 14 at 5:56 PM |
| EKF Diagnostics Sees FY Results To Exceed Market View; Stock Climbs
www.rttnews.com - October 7 at 4:44 PM |
| Is Ekf Diagnostics Holding plc a buy as shares jump 10%+?
uk.finance.yahoo.com - October 7 at 9:46 AM |
Ekf Diagnostics Holding PLC (EKF) Chart for Friday, September, 22, 2017
